| Global change in hepatitis C virus prevalence and cascade of care between 2015 and 2020: a modelling study S Blach, NA Terrault, F Tacke, I Gamkrelidze, A Craxi, J Tanaka, I Waked, ... The Lancet Gastroenterology & Hepatology 7 (5), 396-415, 2022 | 404 | 2022 |
| HCV epidemiology in high-risk groups and the risk of reinfection H Midgard, A Weir, N Palmateer, VL Re III, JA Pineda, J Macías, ... Journal of hepatology 65 (1), S33-S45, 2016 | 230 | 2016 |
| Hepatitis C reinfection after successful antiviral treatment among people who inject drugs: A meta-analysis B Hajarizadeh, EB Cunningham, H Valerio, M Martinello, M Law, ... Journal of hepatology 72 (4), 643-657, 2020 | 162 | 2020 |
| Model projections on the impact of HCV treatment in the prevention of HCV transmission among people who inject drugs in Europe H Fraser, NK Martin, H Brummer-Korvenkontio, P Carrieri, O Dalgard, ... Journal of hepatology 68 (3), 402-411, 2018 | 155 | 2018 |
| Hepatitis C reinfection after sustained virological response H Midgard, B Bjøro, A Mæland, Z Konopski, H Kileng, JK Damås, ... Journal of hepatology 64 (5), 1020-1026, 2016 | 151 | 2016 |
| Hepatitis C elimination among people who inject drugs: challenges and recommendations for action within a health systems framework E Day, M Hellard, C Treloar, J Bruneau, NK Martin, A Øvrehus, O Dalgard, ... Liver International 39 (1), 20-30, 2019 | 144 | 2019 |
| Global prevalence, cascade of care, and prophylaxis coverage of hepatitis B in 2022: a modelling study D Razavi-Shearer, I Gamkrelidze, C Pan, J Jia, T Berg, R Gray, YS Lim, ... The Lancet Gastroenterology & Hepatology 8 (10), 879-907, 2023 | 114 | 2023 |
| Research priorities to achieve universal access to hepatitis C prevention, management and direct-acting antiviral treatment among people who inject drugs J Grebely, J Bruneau, JV Lazarus, O Dalgard, P Bruggmann, C Treloar, ... International Journal of Drug Policy 47, 51-60, 2017 | 79 | 2017 |
| The consensus hepatitis C cascade of care: standardized reporting to monitor progress toward elimination K Safreed-Harmon, S Blach, S Aleman, S Bollerup, G Cooke, O Dalgard, ... Clinical Infectious Diseases 69 (12), 2218-2227, 2019 | 75 | 2019 |
| Hepatitis C treatment uptake among patients who have received opioid substitution treatment: a population-based study H Midgard, JG Bramness, S Skurtveit, JW Haukeland, O Dalgard PloS one 11 (11), e0166451, 2016 | 53 | 2016 |
| Substance use and symptoms of mental health disorders: a prospective cohort of patients with severe substance use disorders in Norway CF Aas, JH Vold, R Gjestad, S Skurtveit, AG Lim, KV Gjerde, EM Løberg, ... Substance abuse treatment, prevention, and policy 16, 1-10, 2021 | 48 | 2021 |
| Integrated treatment of hepatitis C virus infection among people who inject drugs: A multicenter randomized controlled trial (INTRO-HCV) LT Fadnes, CF Aas, JH Vold, RA Leiva, C Ohldieck, F Chalabianloo, ... PLoS medicine 18 (6), e1003653, 2021 | 47 | 2021 |
| Changes in risk behaviours during and following treatment for hepatitis C virus infection among people who inject drugs: the ACTIVATE study H Midgard, B Hajarizadeh, EB Cunningham, B Conway, M Backmund, ... International Journal of Drug Policy 47, 230-238, 2017 | 47 | 2017 |
| Integrated treatment of hepatitis C virus infection among people who inject drugs: study protocol for a randomised controlled trial (INTRO-HCV) LT Fadnes, CF Aas, JH Vold, C Ohldieck, RA Leiva, F Chalabianloo, ... BMC infectious diseases 19, 1-9, 2019 | 41 | 2019 |
| Hepatitis C treatment and reinfection surveillance among people who inject drugs in a low-threshold program in Oslo, Norway H Midgard, K Ulstein, Ø Backe, T Foshaug, H Sørli, K Vennesland, ... International Journal of Drug Policy 96, 103165, 2021 | 31 | 2021 |
| Peer support in small towns: A decentralized mobile Hepatitis C virus clinic for people who inject drugs H Midgard, R Bjørnestad, M Egeland, E Dahl, AK Finbråten, KB Kielland, ... Liver International 42 (6), 1268-1277, 2022 | 20 | 2022 |
| Effect of gender on mortality and causes of death in cirrhotic patients with gastroesophageal varices. A retrospective study in Norway JW Haukeland, MC Småstuen, PP Pålsdatter, M Ismail, Z Konopski, ... PLoS One 15 (3), e0230263, 2020 | 18 | 2020 |
| Efficacy of response-guided directly observed pegylated interferon and self-administered ribavirin for people who inject drugs with hepatitis C virus genotype 2/3 infection … J Grebely, O Dalgard, EB Cunningham, B Hajarizadeh, GR Foster, ... International Journal of Drug Policy 47, 177-186, 2017 | 18 | 2017 |
| Prevalence and correlates of suicide attempts in high-risk populations: a cross-sectional study among patients receiving opioid agonist therapy in Norway JH Vold, EM Løberg, CF Aas, JA Steier, KA Johansson, LT Fadnes BMC psychiatry 22 (1), 181, 2022 | 12 | 2022 |
| Opportunistic treatment of hepatitis C infection among hospitalized people who inject drugs (OPPORTUNI-C): a stepped wedge cluster randomized trial H Midgard, KB Malme, CM Pihl, RM Berg-Pedersen, L Tanum, I Klundby, ... Clinical Infectious Diseases 78 (3), 582-590, 2024 | 10 | 2024 |
